FDA Classifies AI-Powered Radiological Imaging Software

The Food and Drug Administration has designated radiological software utilizing machine learning for quantitative imaging as a Class II device. This classification, which includes a predetermined change control plan, seeks to guarantee the software's safety and effectiveness. It also aims to reduce regulatory burdens, thereby enhancing patient access to beneficial innovative technologies.